Search

US biotech Moderna says its vaccine can be repurposed ‘in weeks’ to deal with coronavirus mutations

Open science has been at the heart of the fight-back against the virus. As other crises loom, this underlines the need for governments to avoid protectionist moves and foster collaborative international research

EU spokesman says EU has been ‘waiting over a year’ for Switzerland to back accord. 

Amid pressure to speed up vaccination programmes some member states are starting to go their own way on securing doses. The EU’s head vaccine official says no country can jump the queue

The pandemic has both spurred on and demonstrated the value of open science, but has also exposed gaps in science policy. Now is a good time for reform, says OECD

Better integration of funding streams is the route to fostering the long-elusive single market for research, says Portugal’s research minister Manuel Heitor

Researchers based in the UK secure the largest number of grants as the EU’s basic research funding body hands out €8.25 million for proof-of-concept projects

EIC takes first step to becoming one of Europe’s biggest venture capital investors as it acquires €178M of shares in emerging science and technology companies. That could increase to €3B over the next seven years

Government to consult on enabling gene edited crop plants and livestock, as scientists tout the potential for a Brexit advantage

There is the promise of improved access to the Chinese market for EU technology and healthcare companies, but disquiet is spreading among politicians over the terms of the new trade agreement